Treatment modalities received by patients with DMI
| Treatment | Mean patient age, years (range; SD) | Gender (male:female) | Mean hemoglobin A1c % (range; SD) | Biopsy rate (%) | Mean time to symptom resolution, days (range; SD) | Recurrence rate (%) |
|---|---|---|---|---|---|---|
| Surgery (n=10) | 43.8 (27–61; ±10) | 2:8 | 8.0 (6.4–11.7; ±2.4) | 100 | 81.6 (25–120; ±40)* | 50 |
| Bed rest (n=34) | 44.9 (21–81; ±13.5) | 16:18 | 9.3 (7.1–13.9; ±2.3) | 47 | 41.7 (5–120; ±33) | 32 |
| NSAID therapy (n=10) | 33.2 (20–57; ±12) | 3:7 | 9.4 (5–15.5; ±3.4) | 30 | 28.5 (10–60; ±14) | 10 |
| Physiotherapy (n=11) | 46.1 (25–67; ±14) | 7:4 | 9.3 (6.4–15.8; ±3.7) | 54.5 | 76.5 (21–180; ±60)* | 18 |
Patients who received combined therapies with NSAID plus surgery or physiotherapy were not included in the analysis (*p<0.05, when compared with NSAID therapy). There were nine cases treated with supportive care only (no NSAIDs or bed rest). This group had an unusually low average A1c of 5.1%. Four of these cases were in patients with post kidney-pancreas transplant. This group was not included in the analysis.
DMI, diabetic muscle infarction; NSAID, non-steroidal anti-inflammatory drug.